CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Viralgen announces planned CEO succession

Neutral
AI Analysis

Summary

Viralgen, an AAV gene therapy CDMO and subsidiary of AskBio (Bayer Group), announced a planned CEO succession. Details of the transition were not included in the available text.

Outcome Details

Planned CEO succession announced at Viralgen; the article excerpt does not name the incoming or outgoing executive.

Importance:4/10
Sentiment:
0.00
management changeCEO successionCDMOgene therapyAAVmanufacturing
Related Companies

Read the original article

Published by PR Newswire Biotech on October 19, 2026 12:00 PM

Read Original